Masonic Cancer Center | Competitive Intelligence Profile
The Masonic Cancer Center, University of Minnesota is the Twin Cities’ only NCI-designated comprehensive cancer center, recognized...

The Masonic Cancer Center, University of Minnesota is the Twin Cities’ only NCI-designated comprehensive cancer center, recognized for its dedication to cancer research, patient care, education, and community outreach. With over 30 years of experience, it focuses on discovering the causes, prevention, detection, and treatment of cancer and cancer-related diseases. The center collaborates with various academic institutions and healthcare partners to advance cancer research and improve patient outcomes.
Website
Headquarters
Minneapolis, Minnesota
Size
501-1000 employees
Industry
Hospitals and Health Care
Specialities
Cancer Research, Carcinogenesis, Cancer Education, Chemoprevention, Bone Marrow Transplant, Immunotherapy for Cancer Treatment, Gene Therapy for Cancer Treatment, Clinical Trials Initiation and Management, Translational Cancer Research, cancer prevention, cancer survivorship, metastatic breast cancer, brain tumor research, head and neck cancers, sarcoma, gynecologic oncology, bone marrow transplant (BMT), cancer community education
🛍️ Masonic Cancer Center Product and Pricing News →
👔 Masonic Cancer Center CEO, Management and Leadership Team →
⚔️ Masonic Cancer Center Alternatives and Competitors →
💼 Masonic Cancer Center Hiring and Layoffs →
🤖 Masonic Cancer Center Developer, Integration and Automation News →
📈 Masonic Cancer Center Financials, Fundraising and Valuation News →


🛍️ Masonic Cancer Center Product and Pricing News
- Masonic Cancer Center will host 'Goldy vs. Cancer' at the Minnesota State Fair on August 22.
- Masonic Cancer Center is hosting the 2025 Survivorship Family Picnic on June 12 at Rosland Park in Edina to celebrate Survivorship Awareness Month.
- Masonic Cancer Center will host a community event with behind-the-scenes tours on May 17.
- The Masonic Cancer Center held its 2025 Annual Research Symposium showcasing innovative research from faculty, students, and partners, including presentations on metastatic lung cancer outcomes, cannabis access barriers for cancer survivors, and a digital resource referral platform.
- Dr. Alexander Khoruts from Masonic Cancer Center received the Distinguished McKnight University Professorship.
- Masonic Cancer Center is conducting a Phase I clinical trial (NCT04056026) using FMT capsules in patients with unresectable NSCLC.
👔 Masonic Cancer Center CEO, Management and Leadership Team
-
Executive Director
[email protected]
⚔️ Masonic Cancer Center Alternatives and Competitors


💼 Masonic Cancer Center Hiring and Layoffs
- Masonic Cancer Center is hiring a Community Health Worker for their Mobile Cancer Community Screening Program in Minnesota.
🤖 Masonic Cancer Center Developer, Integration and Automation News
📈 Masonic Cancer Center Financials, Fundraising and Valuation News
People also viewed
- Cartesian Therapeutics |
- Atara Biotherapeutics |
- Tune Therapeutics |
- Kapadi |
- 2seventy bio |
- Ridecell |
- MOQO |
- Joyride
